Press & News
People are different and so is their cancer, patients should be treated individually.
New The power of precision, For Every Oncologist, Today
With IndiTreat, 2cureX makes the testing of chemotherapeutic agents on patient-derived microtumors an operational reality.
Outcome of the IndiTreat clinical trial (TICC) is published by ASCO prior to its Annual Meeting in June 2021.
June 4, 2021
You can find the the report here